Showing 5441-5450 of 5643 results for "".
- FDA Warns Against Using Raindrop Near Vision Inlayhttps://modernod.com/news/fda-warns-against-using-raindrop-near-vision-inlay/2479749/The FDA today issued an alert about an increased risk for corneal haze in patients with the Raindrop Near Vision Inlay (Optics Medical). The FDA issued the alert after 75% of patients in a postapproval study of the device developed corneal haze, according to a
- Eyevance Pharmaceuticals Acquires Exclusive Rights to Commercialize Flarex in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-acquires-exclusive-rights-to-commercialize-flarex-in-the-united-states/2479751/Eyevance Pharmaceuticals announced the acquisition of Flarex (fluorometholone acetate ophthalmic suspension) 0.1% from Novartis AG. Flarex, approved in the United States, is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea,
- Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM Cloudhttps://modernod.com/news/bausch-lomb-to-launch-first-in-class-surgical-support-applications-for-stellaris-elite-on-ibm-cloud/2479752/Bausch + Lomb and IBM announced the launch of the new eyeTELLIGENCE applications which will run on the IBM Cloud to help eye surgeons and surgical facilities work more efficiently using Stellaris Elite vision enhancement systems. The companies built the eyeTELLIGENCE applications to deliver surge
- New CorneaGen Interactive Education Program To Offer Free Online Training for Surgeonshttps://modernod.com/news/new-corneagen-interactive-education-program-to-offer-free-online-training-for-all-surgeons/2479755/CorneaGen is adding interactive, online courses to its free education program for surgeons around the world. Utilizing an online platform designed for universities, CorneaGen will offer instruction in cutting-edge procedures such as Nano-Thin DSEK and best practices for using transplant devices.
- Johnson & Johnson Vision Launches MyAcuvue Subscription Programhttps://modernod.com/news/johnson-johnson-vision-launches-myacuvue-subscription-program/2479759/Johnson & Johnson Vision announced the launch of its MyAcuvue Subscription Program, developed to provide contact lens wearers greater access and convenience when purchasing an annual supply of Acuvue Brand contact lenses through their eye care professional. “We continue to look for way
- Ellex to Host an AMD Roundtable During AAO 2018https://modernod.com/news/ellex-to-host-an-amd-roundtable-during-aao-2018/2479760/Ellex Medical Lasers Limited announced that it will partner with a panel of leading ophthalmologists to host a roundtable on age-related macular degeneration (AMD) on Friday, October 26, during the American Academy of Ophthalmology (AAO) meeting in Chicago. “Our goal is to start a serious
- Aerie Pharmaceuticals Establishes GMP PRINT Production Facility in an Expanded Global Headquartershttps://modernod.com/news/aerie-pharmaceuticals-establishes-gmp-print-production-facility-in-an-expanded-global-headquarters/2479763/Aerie Pharmaceuticals announced that it has built and commenced operation of its GMP (Good Manufacturing Practices)-validated manufacturing facility for production of ophthalmic implants using the proprietary PRINT (Particle Replication in Non-wetting Templates) Technology platform. As a result o
- Cell Care Therapeutics Raises $4.3 Million in Seed Fundinghttps://modernod.com/news/cell-care-therapeutics-raises-4-3-million-in-seed-funding/2479765/Cell Care Therapeutics announced the closing of a $4.3 million seed round investment from a syndicate of individual investors. This round of funding will be used to develop Cell Care’s manufacturing platform and to ad
- IDx and Topcon Sign Exclusive AI Platform Agreement For the U.S. Markethttps://modernod.com/news/idx-and-topcon-sign-exclusive-ai-platform-agreement-for-the-u-s-market/2479766/AI diagnostics company IDx and Topcon have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the United States. Terms of the deal were not disclosed. The agreement grants exclusive rights to IDx in the US as the only
- Oxurion Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Projecthttps://modernod.com/news/oxurion-extends-partnership-with-retina-global-in-support-of-bolivian-diabetic-retinopathy-boldr-project/2479770/Oxurion NV announced it is extending its partnership with Retina Global, an international nonprofit organization focused on sustainable outcomes to retinal disease management in underserved areas around the world. Oxurion will support Retina Global’s Bolivian Diabetic Retinopathy Project (BOLDR),